• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清谷氨酸合成酶对阿尔茨海默病没有诊断价值。

Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease.

机构信息

Laboratory of Neurochemistry and Behavior, Reference Center for Biological Markers of Memory Disorders, Institute Born-Bunge, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Wilrijk, Belgium.

出版信息

Neurochem Res. 2011 Oct;36(10):1858-62. doi: 10.1007/s11064-011-0504-4. Epub 2011 May 20.

DOI:10.1007/s11064-011-0504-4
PMID:21597934
Abstract

In order to test whether serum glutamine synthetase (GS) is of potential diagnostic value for Alzheimer's disease (AD), we set up a study to compare serum GS concentrations between AD patients and control subjects. The study population (n = 165) consisted of AD patients (n = 94) and age-matched (n = 41) and age-unmatched (n = 30) control subjects. Serum GS analysis was performed by means of ELISA. No significant differences in serum GS levels were found between the AD group and age-matched controls. Age correlated positively with serum GS concentrations in AD patients and control subjects. This study suggests that serum GS levels have no diagnostic value for AD.

摘要

为了测试血清谷氨酰胺合成酶(GS)是否对阿尔茨海默病(AD)具有潜在的诊断价值,我们开展了一项研究,比较了 AD 患者和对照组之间的血清 GS 浓度。研究人群(n = 165)包括 AD 患者(n = 94)和年龄匹配(n = 41)和年龄不匹配(n = 30)的对照组。采用 ELISA 法检测血清 GS 分析。AD 组与年龄匹配对照组之间的血清 GS 水平无显著差异。AD 患者和对照组的血清 GS 浓度与年龄呈正相关。本研究表明,血清 GS 水平对 AD 无诊断价值。

相似文献

1
Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease.血清谷氨酸合成酶对阿尔茨海默病没有诊断价值。
Neurochem Res. 2011 Oct;36(10):1858-62. doi: 10.1007/s11064-011-0504-4. Epub 2011 May 20.
2
Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?脑脊液、血清和大脑中的谷氨酰胺合成酶:阿尔茨海默病的诊断标志物?
Arch Neurol. 1999 Oct;56(10):1241-6. doi: 10.1001/archneur.56.10.1241.
3
Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged.阿尔茨海默病患者脑脊液中谷氨酰胺合成酶的总水平未发生变化。
Neurobiol Aging. 2015 Mar;36(3):1271-3. doi: 10.1016/j.neurobiolaging.2014.12.010. Epub 2014 Dec 12.
4
Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.阿尔茨海默病患者脑脊液中谷氨酰胺合成酶的检测:一种潜在的诊断生化标志物。
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11949-53. doi: 10.1073/pnas.89.24.11949.
5
Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological progression.阿尔茨海默病三转基因动物模型海马回星形胶质细胞中的谷氨酰胺合成酶不受病理进展的影响。
Biogerontology. 2013 Dec;14(6):777-87. doi: 10.1007/s10522-013-9456-1. Epub 2013 Aug 30.
6
Plasma concentrations of glutamate and its metabolites in patients with Alzheimer's disease.
J Am Osteopath Assoc. 1993 Jun;93(6):670-6.
7
Immunoassay for serum glutamine synthetase in serum: development, reference values, and preliminary study in dementias.
Clin Chem. 2002 Feb;48(2):375-8.
8
Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.载脂蛋白 E4 血清浓度可提高药物治疗的阿尔茨海默病患者与药物治疗的帕金森病患者以及年龄匹配的正常对照者诊断的灵敏度和特异性。
Curr Alzheimer Res. 2012 Dec;9(10):1149-67. doi: 10.2174/156720512804142868.
9
Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.
J Neurochem. 1997 Jun;68(6):2451-7. doi: 10.1046/j.1471-4159.1997.68062451.x.
10
Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.阿尔茨海默病中谷氨酰胺合成酶的神经元表达表明与星形胶质细胞的代谢相互作用存在严重受损。
Neurochem Int. 2000 Apr;36(4-5):471-82. doi: 10.1016/s0197-0186(99)00150-3.

引用本文的文献

1
Glial Glutamine Homeostasis in Health and Disease.健康与疾病中的胶质谷氨酰胺稳态
Neurochem Res. 2023 Apr;48(4):1100-1128. doi: 10.1007/s11064-022-03771-1. Epub 2022 Nov 2.
2
¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.¹H-和¹³C-NMR 光谱分析 Thy-1-APPSL 小鼠脑提取物表明阿尔茨海默病的代谢变化。
J Neural Transm (Vienna). 2015 Apr;122(4):541-50. doi: 10.1007/s00702-015-1387-3. Epub 2015 Mar 6.

本文引用的文献

1
The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.血浆 Aβ 水平与轻度认知障碍老年人痴呆的关系。
J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005. Epub 2011 Mar 26.
2
Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.阿尔茨海默病患者和非阿尔茨海默病患者的血浆淀粉样蛋白-β形成。
J Alzheimers Dis. 2010;21(1):291-301. doi: 10.3233/JAD-2010-091501.
3
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.
阿尔茨海默病在血液、血浆和血清中的生物标志物候选物。
CNS Neurosci Ther. 2009 Winter;15(4):358-74. doi: 10.1111/j.1755-5949.2009.00104.x. Epub 2009 Oct 14.
4
No correlation between time-linked plasma and CSF Abeta levels.血浆和脑脊液 Abeta 水平与时间无相关性。
Neurochem Int. 2009 Dec;55(8):820-5. doi: 10.1016/j.neuint.2009.08.006. Epub 2009 Aug 18.
5
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.血浆和脑脊液中的肽和蛋白质作为阿尔茨海默病预测、诊断及治疗效果监测的生物标志物。
Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Epub 2008 Aug 7.
6
No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.在确诊的阿尔茨海默病中,脑脊液生物标志物与APOEε4、斑块和缠结负荷之间无关联。
Brain. 2007 Sep;130(Pt 9):2320-6. doi: 10.1093/brain/awm136. Epub 2007 Jun 22.
7
Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.Ts65Dn小鼠大脑中不同年龄的胆碱乙酰转移酶活性,Ts65Dn小鼠是唐氏综合征及相关神经退行性疾病的动物模型。
J Neurochem. 2006 Apr;97(2):515-26. doi: 10.1111/j.1471-4159.2006.03769.x. Epub 2006 Mar 15.
8
Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients.阿尔茨海默病患者前额叶皮质中的谷氨酸代谢酶
Neurochem Res. 2005 Nov;30(11):1443-51. doi: 10.1007/s11064-005-8654-x.
9
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.用于轻度认知障碍和早期阿尔茨海默病的脑脊液生物标志物。
Clin Neurol Neurosurg. 2005 Apr;107(3):165-73. doi: 10.1016/j.clineuro.2004.10.011.
10
Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.针对淀粉样前体蛋白(APP)的β淀粉样蛋白(Aβ)区域的反义核酸可降低老年加速衰老小鼠大脑中的氧化标志物水平。
Brain Res. 2004 Aug 20;1018(1):86-96. doi: 10.1016/j.brainres.2004.05.048.